Brad Hively - 03 Jun 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jun 2025, 18:51:15 UTC
Prior SEC filing
28 Apr 2025
Next SEC filing
21 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively

Key filing fact

Brad Hively filed Form 4 for Oncology Institute, Inc. (TOI) on 05 Jun 2025.

Key facts

  • This page summarizes Brad Hively's Form 4 filing for Oncology Institute, Inc. (TOI).
  • 10 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 05 Jun 2025, 18:51.

Change

  • Previous filing in this sequence was filed on 28 Apr 2025.
  • Current net transaction value: -$3,989,582.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001891124 Primary reporting owner

Hively Brad

Relationship
Director
Address
C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively
Signature date
05 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TOI transaction

Common Stock

Options Exercise

Transaction value
$581,849
Shares
+684,528
Change %
+96%
Price
$0.8500
Shares after
1,396,561
Date
03 Jun 2025
Ownership
Direct
TOI transaction

Common Stock

Options Exercise

Transaction value
$50,659
Shares
+105,320
Change %
+7.5%
Price
$0.4810
Shares after
1,501,881
Date
03 Jun 2025
Ownership
Direct
TOI transaction

Common Stock

Options Exercise

Transaction value
$245,525
Shares
+131,297
Change %
+8.7%
Price
$1.87
Shares after
1,633,178
Date
03 Jun 2025
Ownership
Direct
TOI transaction

Common Stock

Options Exercise

Transaction value
$804,491
Shares
+946,460
Change %
+58%
Price
$0.8500
Shares after
2,579,638
Date
03 Jun 2025
Ownership
Direct
TOI transaction

Common Stock

Sale

Transaction value
$5,360,587
Shares
-1,867,605
Change %
-72%
Price
$2.87
Shares after
712,033
Date
03 Jun 2025
Ownership
Direct
TOI transaction

Common Stock

Sale

Transaction value
$311,519
Shares
-108,532
Change %
-15%
Price
$2.87
Shares after
603,501
Date
03 Jun 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TOI transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
+684,528
Change %
Price
$0.000000
Shares after
0
Date
03 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
684,528
Exercise price
$0.8500
Footnotes
F2, F6
TOI transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
+105,320
Change %
Price
$0.000000
Shares after
0
Date
03 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
105,320
Exercise price
$0.4810
Footnotes
F3, F6
TOI transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
+131,297
Change %
Price
$0.000000
Shares after
0
Date
03 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
131,297
Exercise price
$1.87
Footnotes
F4, F6
TOI transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
+946,460
Change %
Price
$0.000000
Shares after
0
Date
03 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
946,460
Exercise price
$0.8500
Footnotes
F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents sale of Common Stock acquired from previously vested RSU awards.

Footnote F2

These options vested monthly for 36 months following November 12, 2021.

Footnote F3

These options vested monthly starting March 17, 2023, with cancellation of remaining options pursuant to Note 6 below.

Footnote F4

These options vested monthly starting November 17, 2022, with cancellation of remaining options pursuant to Note 6 below.

Footnote F5

These options vested monthly for 48 months following December 2, 2019.

Footnote F6

Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .